Your browser doesn't support javascript.
loading
Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier.
Alshaikh, Rasha A; Essa, Ebtessam A; El Maghraby, Gamal M.
Affiliation
  • Alshaikh RA; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
  • Essa EA; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
  • El Maghraby GM; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
Pharm Dev Technol ; 25(2): 168-177, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31642728
ABSTRACT
Fenofibrate is antihyperlipidemic which has low and variable oral bioavailability due to erratic dissolution characteristics. Niacin showed a potential atheroprotective effects suggesting possible co-administration with fenofibrate with a potential for development of fixed dose combination. The chemical structure of both drugs highlights the opportunity for interaction upon co-processing due to the existence of complementary hydrogen bonding sites. Accordingly, fenofibrate and niacin were co-processed by wet co-grinding and the resulting product was assessed using scanning electron microscopy, FTIR, thermal analysis and X-ray diffraction in addition to dissolution studies. The instrumental analysis indicated the development of submicron fenofibrate crystals stabilized over the surface of niacin crystals. The developed submicron crystals showed fast dissolution of fenofibrate depending on the relative proportions of fenofibrate to niacin. Co-processing of both drugs at dose ratio which contained higher proportion of niacin resulted in further enhancement in the dissolution rate. This further enhancement was attributed to the hydrotropic effect of niacin which was proved by solubility study in addition to size reduction. This supposition was confirmed from the inferior dissolution of fenofibrate from the physical mixture. The study introduces fenofibrate/niacin as potential fixed dose combination for augmented dissolution rate and pharmacological effects.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Fenofibrate / Drug Carriers / Niacin Language: En Journal: Pharm Dev Technol Year: 2020 Type: Article Affiliation country: Egypt

Full text: 1 Database: MEDLINE Main subject: Fenofibrate / Drug Carriers / Niacin Language: En Journal: Pharm Dev Technol Year: 2020 Type: Article Affiliation country: Egypt